LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Withaferin A | 10.0 | uM | LJP6 | 2 | G13 | 72 | hr | 1097 | 568 | 3769 | 0.1507 | -0.1981 |
BT-20 | Withaferin A | 10.0 | uM | LJP6 | 3 | G13 | 72 | hr | 1097 | 553 | 3769 | 0.1467 | -0.2037 |
BT-20 | WYE-125132 | 10.0 | uM | LJP6 | 1 | L07 | 72 | hr | 1097 | 957 | 3769 | 0.2539 | -0.0525 |
BT-20 | WYE-125132 | 10.0 | uM | LJP6 | 2 | L07 | 72 | hr | 1097 | 1090 | 3769 | 0.2892 | -0.0027 |
BT-20 | WYE-125132 | 10.0 | uM | LJP6 | 3 | L07 | 72 | hr | 1097 | 982 | 3769 | 0.2605 | -0.0431 |
BT-20 | WZ3105 | 10.0 | uM | LJP5 | 1 | D19 | 72 | hr | 1097 | 624 | 3769 | 0.1655 | -0.1771 |
BT-20 | WZ3105 | 10.0 | uM | LJP5 | 2 | D19 | 72 | hr | 1097 | 636 | 3769 | 0.1687 | -0.1726 |
BT-20 | WZ3105 | 10.0 | uM | LJP5 | 3 | D19 | 72 | hr | 1097 | 724 | 3769 | 0.1921 | -0.1397 |
BT-20 | XMD11-50 | 10.0 | uM | LJP6 | 1 | P07 | 72 | hr | 1097 | 1182 | 3769 | 0.3136 | 0.0317 |
BT-20 | XMD11-50 | 10.0 | uM | LJP6 | 2 | P07 | 72 | hr | 1097 | 1246 | 3769 | 0.3305 | 0.0557 |
BT-20 | XMD11-50 | 10.0 | uM | LJP6 | 3 | P07 | 72 | hr | 1097 | 1394 | 3769 | 0.3698 | 0.1111 |
BT-20 | Y39983 | 10.0 | uM | LJP6 | 1 | P01 | 72 | hr | 1097 | 1451 | 3769 | 0.3849 | 0.1324 |
BT-20 | Y39983 | 10.0 | uM | LJP6 | 2 | P01 | 72 | hr | 1097 | 1515 | 3769 | 0.4019 | 0.1563 |
BT-20 | Y39983 | 10.0 | uM | LJP6 | 3 | P01 | 72 | hr | 1097 | 1594 | 3769 | 0.4229 | 0.1859 |
BT-20 | YM 201636 | 10.0 | uM | LJP5 | 1 | N07 | 72 | hr | 1097 | 1048 | 3769 | 0.2780 | -0.0184 |
BT-20 | YM 201636 | 10.0 | uM | LJP5 | 2 | N07 | 72 | hr | 1097 | 1245 | 3769 | 0.3303 | 0.0553 |
BT-20 | YM 201636 | 10.0 | uM | LJP5 | 3 | N07 | 72 | hr | 1097 | 985 | 3769 | 0.2613 | -0.0420 |
BT-20 | ZSTK474 | 10.0 | uM | LJP6 | 1 | M13 | 72 | hr | 1097 | 982 | 3769 | 0.2605 | -0.0431 |
BT-20 | ZSTK474 | 10.0 | uM | LJP6 | 2 | M13 | 72 | hr | 1097 | 889 | 3769 | 0.2358 | -0.0779 |
BT-20 | ZSTK474 | 10.0 | uM | LJP6 | 3 | M13 | 72 | hr | 1097 | 906 | 3769 | 0.2404 | -0.0716 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 658 | 3551 | 3846 | 0.9233 | 0.9074 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 658 | 3643 | 3846 | 0.9472 | 0.9363 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 658 | 3476 | 3846 | 0.9038 | 0.8839 |
Hs 578T | Sigma A6730 | 0.04 | uM | LJP5 | 1 | B24 | 72 | hr | 658 | 3740 | 3846 | 0.9724 | 0.9667 |
Hs 578T | Sigma A6730 | 0.04 | uM | LJP5 | 2 | B24 | 72 | hr | 658 | 3777 | 3846 | 0.9820 | 0.9783 |